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This Special Issue summarizes an ISPOR Consensus Develop-
ment Workshop held in November 2007 on methods for estimat-
ing and applying quality-adjusted life-years (QALYs) [1–7].
Participants were charged with the agenda of “Moving the
QALY Forward,” with the primary objective of seeking consen-
sus on how to deﬁne and reﬁne the QALY. The authors analyze
the underlying assumptions, offer critiques of QALY methods,
and propose alternative approaches. Although the contributions
provide a reasonable overview of the current state of QALYs,
they conﬁrm several rather unfortunate truths. First, the scientiﬁc
foundations of conventional QALYs remain unsatisfactory—
being essentially unchanged since their inception. Second, many
practitioners and policymakers remain content to apply QALYs
uncritically and unapologetically for the purposes of health-
technology assessment (HTA). As a consequence, one must con-
clude that the prospects for moving the science and practice of
QALYs forward are discouraging.
It is remarkable that three decades of QALY research have
yielded so little substantive methods development. This lack of
progress is particularly discouraging in light of the rapid inter-
national growth of HTA and increased attention to comparative
effectiveness issues in the United States. Rather than moving
HTA science and practice forward, QALY research appears to be
stuck in a methodological trafﬁc jam.
Unsatisfactory Theory
It is clear that strong institutional demand exists for a simple,
intuitive metric for assessing health status across a broad range of
applications that can be applied with little explanation or tech-
nical expertise. Most participants at this Workshop seemed to
agree with Smith et al. [1] that “the lack of a simple better
measure as an alternative makes the QALY an indispensable
tool.” The simplicity of the QALY as a universal health-care
metric certainly has lead to its broad acceptance, but it comes at
the cost of several limiting assumptions. The signiﬁcance of these
assumptions generally are poorly understood, or simply ignored,
among practitioners and policymakers despite the assumptions’
repeated failure in careful tests of validity and reliability.
Apart from Kahneman’s [4] suggestion that we abandon any
attempt to measure utility and leave health evaluations entirely to
the judgment of a small group of experts, Nord et al. [3] offer the
only serious critique of conventional QALYs in this collection.
Their concerns include well-known empirical and conceptual
deﬁciencies such as inconsistencies among values obtained from
standard-gamble, time-trade-off, and visual-analog-scale elicita-
tion formats and linearity assumptions that violate diminishing
marginal utility. It is not surprising to survey researchers that
health-state utility values are inﬂuenced by the elicitation format.
Because the context provided in the elicitation format matters,
the best strategy is to elicit preferences with formats that
mimic the policy-relevant context as closely as possible. Other
preference-elicitation methods such as conjoint analysis or
discrete-choice experiments offer opportunities to simulate a
more realistic clinical decision context [8].
Even if QALY researchers were to adopt better measurement
methods, any resulting improvements would be meaningless if
users insist on linear, additive utility. One of the fundamental
principles of economics is diminishing marginal utility, which
requires that values be nonlinear. Marginal values of a given
commodity decrease as quantities already consumed increase.
Health is not exempt from this virtually universal principle, yet
standard HTA practice ignores the fundamental nonlinearity of
preferences. A signiﬁcant movement forward would be to
acknowledge and embrace evidence of preference nonlinearities
in everyday QALY applications.
Uncritical Practice
Weinstein et al. [2] acknowledge that “the conventional QALY
remains a powerful conceptual tool” and that “the conventional
QALY retains an important role in health care decision making.”
Nevertheless, moving the science and practice of QALY research
forward requires going beyond orthodoxy. Researchers must
help decision-makers identify circumstances where the beneﬁts
of relaxing QALY assumptions or considering alternative
approaches justify at least a modest increase in analytical com-
plexity. For example, nowhere in this special issue is there
mention of the approach adopted by the Institute for Quality and
Efﬁciency in Health Care (IQWiG) in Germany. IQWiG is
playing an increasingly important role in HTA thinking, and has
concluded that QALYs are both unethical and unconstitutional
within the context of the German health system [9]. Such a
strong rejection in Germany of the QALY approach to HTA is an
interesting exception to the common assumption that conven-
tional QALYs are essential to prudent allocation of health care
resources.
A Poor Prognosis
It is clear that I share Nord et al.’s [3] view that, in view of the
limitations of the conventional QALY model, “more sophisti-
cated models may be required.” Unfortunately, because decision-
makers clearly have a strong revealed preference for simplicity,
various proposed improvements to QALY measurement have
remained in the pages of academic journals. Decision-makers’
demand for a simple solution to HTA has forced investigators
with an interest in policy-relevance to devote scarce research
resources to lower priority topics. For example, Lipscomb et al.
[5] discuss challenges in translating health-state descriptions
from one health-related quality of life instrument into another.
Although this certainly is a practical concern, it is of secondary
importance in the QALY research agenda. The highest priority
research problem is not how to describe health states, but how to
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obtain a valid utility estimate for any particular description.
Similarly, several articles in this issue devote considerable atten-
tion to equity considerations. There is little likelihood that equity
considerations will be neglected in health-care decision-making.
However, our understanding of public decision-making suggests
that there are considerable grounds for concern that equity will
dominate decisions and that consideration of efﬁciency will be
neglected.
QALY research and practice reﬂect a general consensus that
health-care decisions are fundamentally different than other
public investments. Thus, HTA deviates from common economic
evaluation practices in virtually every other area of societal
decision-making. One wonders how much longer the particular-
ism enjoyed by health-care stakeholders will survive in the com-
petition for increasingly scarce public resources and the relentless
rise in health-care costs.
The entrenched state of the practice in HTA and devotion to
the QALY leaves serious researchers in an awkward position. We
all should have an interest in developing more valid indicators
of health outcomes that will improve the efﬁciency of health-
care spending. On the other hand, proposed improvements in
QALY methods are not likely to have much traction with
decision-makers until researchers are able to document a
signiﬁcant—perhaps dramatic—misallocation of health-care
resources as a result of the distortions introduced by using an
oversimpliﬁed health index.
How to Move Forward
Despite the wide acceptance of QALYs among health economists,
nearly all nonhealth economists view the concept and implemen-
tation of this metric with considerable skepticism. Moving the
QALY forward requires taking such outside skepticism regarding
the HTA status quo more seriously. The research agenda should
include several important questions, such as:
1. What lessons can be learned from 50 years of economic
research in Europe and the United States on optimal public
investments?
2. What lessons can be learned from the ongoing German
experiment to apply a completely different approach to
HTA?
3. What is the cost in money and human suffering of allocating
scarce societal resources using QALYs?
4. How can users be trained to accept and implement more
valid, if somewhat more complicated, approaches to HTA?
Trafﬁc jams are a consequence of poor planning, perverse
incentives, and inefﬁcient use of scarce resources. Similarly, the
lack of movement in health-technology trafﬁc signals a failure to
resist incentives to endorse simplistic approaches to HTA and to
demand that health care decision makers take their responsibility
to the commonweal seriously enough to adopt more valid
methods.
I have beneﬁted from conversations with John Bridges and his comments
on an earlier draft of this editorial.
Source of ﬁnancial support: Funding for the ISPOR “Building a Pragmatic
Road: Moving the QALY Forward” Consensus Development Workshop
was made possible in part by grant 1R13 HS016841-01 from the Agency
for Healthcare Research and Quality. The views expressed in written
conference materials or publications and by speakers and moderators
neither necessarily reﬂect the ofﬁcial policies of the Department of Health
and Human Services; nor does mention of trade names, commercial prac-
tices, or organizations imply endorsement by the US government. Funding
for this Value in Health Special Issue, “Moving the QALY Forward:
Building a Pragmatic Road” was made possible in part by Contract No.
HHSN261200800148P from the National Cancer Institute.
References
1 Smith MD, Drummond M, Brixner D. Moving the QALY forward:
rationale for change. Value Health 2009;12(Suppl. 1):S1–4.
2 Weinstein M, Torrance G, McGuire A. QALYs: the basics. Value
Health 2009;12(Suppl. 1):S5–9.
3 Nord E, Daniels N, Kamlet M. QALYs: some challenges. Value
Health 2009;12(Suppl. 1):S10–5.
4 Kahneman D. A different approach to the QALY. Value Health
2009;12(Suppl. 1):S16–7.
5 Lipscomb J, Drummond M, Fryback D, et al. Retaining, and
enhancing, the QALY. Value Health 2009;12(Suppl. 1):S18–26.
6 Kind P, Elston Lafata J, Matuszewski K, Raisch D. The use of
QALYs in clinical and patient decision-making: issues and pros-
pects. Value Health 2009;12(Suppl. 1):S27–30.
7 Drummond M, Brixner D, Gold M, et al. Towards a consensus on
the QALY. Value Health 2009;12(Suppl. 1):S31–5.
8 Bridges J, Onukwugha E, Johnson FR, Hauber AB. Patient prefer-
ence methods—A patient centered evaluation paradigm. ISPOR
CONNECTIONS 2007;13:4–7.
9 Kolominsky-Rabas PL, Caro JJ. The Hanover consensus: helpful
for German decision-makers? Value Health 2008;11:539–44.
Editorial S39
